The comparison of effectiveness of psychotherapy and pharmacotherapy to improvement of nausea and vomiting of pregnancy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201304035931N2

Enrollment

Registered

2013-04-16

Start date

2013-02-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting. Vomiting of pregnancy, unspecified

Interventions

Intervention 1: This group will be given pyridoxine hydrochloride (40 mg daily) for 3 weeks. Intervention 2: Group psycotherapy , will be given treatment session 1 hour weekly for 3 weeks. Interventi

Treatment - Drugs

Treatment - Other

This group will be given pyridoxine hydrochloride (40 mg daily) for 3 weeks.

Group psycotherapy , will be given treatment session 1 hour weekly for 3 weeks

Control group do not recieve any intervention except routin notritional nausea/vomoting.

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age above 18 years; singleton pregnancy and first trimester.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Naesea/vomiting. Timepoint: Beginning of the study and after 4 weeks. Method of measurement: Rodesh scale.	—

Secondary

Measure	Time frame
Anxiety and depression. Timepoint: beginning, after 3 weeks, 1 month follow-up. Method of measurement: hospital anxiety and depression scale (HADS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahbobeh Faramarzi

Babol University of Medical Sciences

mahbob330@yahoo.com+98 11 1329 4456

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026